By combining the disciplines of mathematics and computer science with molecular biology, Compugen leads the field of computational genomics and proteomics, the study of genes and proteins. Compugen's leading-edge products and services give scientists and researchers new tools to effectively analyze the vast amounts of new genomic and proteomic data, allowing the raw data to be transformed into useful information that can lead to the creation of new drugs and therapies.
When the company went in search of an effective data protection solution, its requirements consisted of two separate business areas. Compugen required backup of its internal network servers with corporate operations and research data, and also the servers storing the company's innovative Internet site LabOnWeb.com, the first-ever life science research engine. LabOnWeb.com is an online collection of gene discovery tools designed to accelerate work in the lab, improve the quality and accuracy of experiments, simplify the delivery of information and help researchers make more informed decisions throughout the discovery process. LabOnWeb.com's servers are housed in a co-location facility 50 miles from Compugen's headquarters.
Compugen selected two Overland Data LibraryPro automated tape libraries with Sony's Advanced Intelligent Tape(1) (AIT(1)) technology. One multi-terabyte library is located at the company's headquarters; the other is backing up data from Network Appliance filers and UNIX servers for the LabOnWeb.com site.
According to Gary Mulder, UNIX systems administrator at Compugen, the LibraryPro was a clear winner during a competitive product evaluation based on its small form factor, the modular scalability, superior feature set and remote monitoring capability of the Overland library.
"The features we liked about the Overland libraries were the modularity, of course," said Mulder. "There's no other product out there that has the modularity that Overland has. We could choose to have zero, one or two drives in a module so we could really add drives as needed. We weren't limited to a four-drive jukebox or a two-drive jukebox."
For the library installed at the co-location site 50 miles away, Overland's Web TLC(TM) (Total Library Control) was installed so Mulder can remotely monitor and manage the library via a Web browser from anywhere in the world. Web TLC creates a virtual front panel menu system, giving the remote operator full control of all library functions. "We're enthusiastic about the remote monitoring capability, because one installation is at a co-located facility 50 miles up the road from us. We don't want to be driving up there simply to find out the state of the library and have to do front panel administration. Web TLC enables us to manage the library from a Web browser as if we were in front of it, which is great. Administering a library remotely is a major time saver."
Overland's LibraryPro combines the company's ultra-reliable Mainframe Class(TM) robotics technology with the inherent advantages of Sony's AIT technology, which offers the highest data transfer rate, cartridge capacity, longest head life and fastest time to data of all mid-range backup systems in their price class. LibraryPro allows customers to scale the capacity and performance in increments for a customized solution to precisely match their specific storage needs, not locking them into restrictive monolithic library designs that dictate fixed drive and cartridge slot configurations.
Overland products are backed by the company's innovative Guaranteed Up Time Service (GUTS(TM)) warranty program guaranteeing 99% uptime performance and 100% data recovery, the only guarantee of its kind in the industry.
About CompugenCompugen (NASDAQ:CGEN) develops and markets platforms, tools and products that accelerate post-genomic research, the advanced study of proteins and protein pathways and drug target discovery. These products and services include: LEADS, Gencarta(TM), DNA Chip design, Z3, LabOnWeb.com and Bioccelerators. Compugen's in-house molecular biology laboratories provide validation of its methodologies and also conduct original genomic and proteomic research. For additional information, visit Compugen's Corporate Web Site at www.cgen.com and the Company's Internet research engine for molecular biologists, www.LabOnWeb.com.
About OverlandOverland Data, Inc. (NASDAQ:OVRL) is a global supplier of innovative data storage and storage automation solutions for computer networks. The Company's award-winning DLT LibraryXpress(TM) SmartScale Storage(R) architecture has set the standard for intelligent automated storage and scalability and established Overland as a leader in the mid-range tape storage market. Today, Overland is broadening its product line and technology offerings to address additional segments of the storage market, including the entry-level small-business market, as well as the higher-end enterprise environment. Overland's patented Variable Rate Randomizer (VR2(TM)) data encoding technology, capable of substantially increasing the capacity and throughput of linear tape formats, is being applied by the Company to its entry-level tape drive offerings. It has also been licensed to Imation Corp., Seagate Technology, StorageTek and Tandberg Data. Overland products, acclaimed for their quality and reliability, are sold worldwide through leading OEMs, including Compaq, Fujitsu Siemens Computers, Groupe Bull, IBM and NCR commercial distributors such as Bell Microproducts, Ingram Micro and Tech Data Corp., as well as storage integrators and value-added resellers.
(1) Advanced Intelligent Tape and AIT are trademarks of Sony Electronics.
This Statement for Overland:Except for the factual statements made herein, the information contained in this press release consists of forward-looking statements that involve risks, uncertainties and assumptions that are difficult to predict. Words and expressions reflecting optimism and satisfaction with current prospects, as well as words such as "believe," "intends," "expects," "plans," "anticipates," and variations thereof, identify forward-looking statements, but their absence does not mean that a statement is not forward-looking. Such forward-looking statements are not guarantees of performance, and the Company's actual results could differ materially from those contained in such statements. Factors that could cause or contribute to such differences include unexpected shortages of critical components, rescheduling or cancellation of customer orders, loss of a major customer, the timing and market acceptance of new product introductions by the Company and its competitors, general competition and price pressures in the marketplace, and the Company's ability to control costs and expenses. Reference is also made to other factors set forth in the Company's filings with the Securities and Exchange Commission including the "Risk Factors," "Management's Discussion and Analysis" and other sections of the Company's Form 10-K for the most recently completed fiscal year. These forward-looking statements speak only as of the date of this release, and the Company undertakes no obligation to publicly update any forward-looking statements to reflect new information, events or circumstances after the date of this release.
This Statement for Compugen:This press release includes forward-looking statements based on management's current expectations. Factors that could cause future results to differ materially from such expectations include, but are not limited to: the ability to secure future funding; the success of the Company's research strategy; the applicability of the discoveries made therein; the difficulties inherent in the development of pharmaceuticals, including uncertainties as to the timing and results of pre-clinical studies; delayed achievements of milestones; reliance on collaborators; uncertainty as to whether the Company's potential products will succeed in entering human clinical trials and uncertainty as to the results of such trials; uncertainty as to whether adequate reimbursement for these products will exist from the government, private healthcare insurers and third-party players; and the uncertainties as to the extent of future government regulation of the pharmaceutical business.
This press release contains "forward-looking statements." These statements include words like "may," "expects," "believes," and "intends," and describe opinions about future events. These forward-looking statements are subject to risks and uncertainties that may cause the actual results, performance or achievements of Compugen to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Some of these risks are: changes in relationships with collaborators; the impact of competitive products and technological changes; risks relating to the development of new products; the ability to implement technological improvements; the ability of Compugen to obtain and retain customers. These and other factors are identified and more fully explained under the heading "Risk Factors" in Compugen's Registration Statement on Form F-1 filed with the Securities and Exchange Commission.
CONTACT: Overland Data, Inc., San Diego
858/571-5555
Christopher Calisi
ccalisi@overlanddata.com
Vernon LoForti
vloforti@overlanddata.com
http://www.overlanddata.com
or
JPR Communications, Encino, Calif.
Judy Smith, 818/386-0403
judys@jprcom.com
http://www.jprcom.com
